View Item 

Pipeline pharmacogenetics: A novel approach to integrating pharmacogenetics into drug development

Access Status
Fulltext not available
Authors
Akkari, Patrick
Swanson, T.
Crenshaw, D.
Grossman, I.
Sundseth, S.
Burns, D.
Roses, A.
Date
2009
Type
Journal Article

Metadata
Show full item record
Citation
Akkari, P. and Swanson, T. and Crenshaw, D. and Grossman, I. and Sundseth, S. and Burns, D. and Roses, A. 2009. Pipeline pharmacogenetics: A novel approach to integrating pharmacogenetics into drug development. Current Pharmaceutical Design. 15 (32): pp. 3754-3763.
Source Title
Current Pharmaceutical Design
DOI
ISSN
School
School of Biomedical Sciences
URI
Collection
Abstract

There has been a decline in the number of new drugs registered over the past decade and regulatory concerns for safety as well as payer concerns for efficacy have focused attention on stratified medicine. Integration of pharmacogenetics into the drug development pipeline will contribute to the development of new stratified drugs. We describe here the concept of pipeline pharmacogenetics and its application throughout the phases of drug discovery. Pipeline pharmacogenetics enables the evaluation of the genetic contribution to safety potentially lowering barriers to registration as well as providing rationale for efficacy and enabling co-development of genetic in vitro diagnostics. © 2009 Bentham Science Publishers Ltd.